| Literature DB >> 29412368 |
Daniela Galvão de Almeida Prado1, Giédre Berretin-Felix2, Renata Resina Migliorucci3, Mariana da Rocha Salles Bueno3, Raquel Rodrigues Rosa2, Marcela Polizel4, Isadora Ferraz Teixeira5, Maria Beatriz Duarte Gavião6.
Abstract
OBJECTIVES: The esthetic and functional results of orthognathic surgery of severe dentofacial deformities are predictable, however there are differences regarding the effects on stomatognathic system. The aim was to investigate the effects of orofacial myofunctional therapy (OMT) on the masticatory function in individuals with dentofacial deformity submitted to orthognathic surgery (OGS).Entities:
Mesh:
Year: 2018 PMID: 29412368 PMCID: PMC5777416 DOI: 10.1590/1678-7757-2017-0164
Source DB: PubMed Journal: J Appl Oral Sci ISSN: 1678-7757 Impact factor: 2.698
Figure 1Flow chart: sample distribution according to groups and period of evaluation
Figure 3(a) Electromyography diagram showing the chewing act, (b) Electromyography diagram showing the chewing cycle
Figure 2Aspects addressed during therapeutic sessions
Mean values (standard deviation) of OMES-E scores in each period for the treated group (TG), untreated group (UTG) and control group (CG)
| Maximum score of OMES-E | ||
|---|---|---|
| TG | UTG | |
| P0 | 13.23 | 15 |
|
| ±3.19 | |
| P1 | 15,92 | 15,4 |
|
| ±366 | |
| P2 | 16 | 16,2 |
| ±3.51 | ±3.67 | |
| GC | 19,62 | 19,3 |
| ±0.65 | ±1.34 | |
p<0.05 statistically significant
Legend: P0: before surgery; P1: 3 months after surgery; P2: 6 months after surgery
TG: treated group; UTG: untreated group; CG: control group Statistical tests used: Comparison between periods: Anova/Tukey; Comparison with control: Kruskal-Wallis/Dunn
Mean values (±standard deviation) of the OMES-E protocol items according to period of evaluation for the TG, UTG and CG
| Bite# (maximum score: 4) | Masticatory type# (maximum score: 10) | Movements of the head+ | Altered head posture+ | Food escape+ | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TG | UTG | TG | UTG | TG | UTG | TG | UTG | TG | UTG | |||
| n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | |||||||
| Mean±SD | 3.61 | 3.9 | 4.3 | 6.20 | Presence | 4 (31) | 2 (20) | 5 (38) | 8 (80) | 0 (0) | 1 (10) | |
| P0 | ±0.87 | ±0.31 | ±2.56 | ±3.3 | Absence | 9 (69) | 8 (80) | 8 (62) | 2 (20) | 13 (100) | 9 (90) | |
| Median | 4.00 | 4.00 | 4.00 | 6.00 | ||||||||
| Mean±SD | 3.77 | 4.00 |
| 6.40 | Presence | 1 (8) | 4 (40) | 1 (8) | 6 (60) | 0 (0) | 0 (0) | |
| P1 | ±0.83 | ±0.00 | ±3.04 | ±3.09 | Absence | 12 (92) | 6 (60) | 12(92) | 4 (40) | 13 (100) | 10 (100) | |
| Median | 4.00 | 4.00 | 6.00 |
|
|
| ||||||
| Mean±SD | 3.69 | 3.70 | 6.92 | 7.60 | Presence | 3 (23) | 3 (30) | 5 (38) | 7 (70) | 0 (0) | 1 (10) | |
| P2 | ±0.86 | ±0.95 | ±2.78 | ±2.63 | Absence | 10 (77) | 7 (70) | 8 (62) | 3 (30) | 13 (100) | 9 (90) | |
| Median | 4.00 | 4.00 | 8.00 | 8.00 |
| |||||||
| Mean±SD | 3.92 | 3.90 | 10.00 | 9.60 | Presence | 0 (0) | 0 (0) | 4 (31) | 2 (20) | 0 (0) | 0 (0) | |
| CG | ±0.27 | ±0.32 | ±0.00 | ±1.3 | Absence | 13 (100) | 10 (100) | 9 (69) | 8 (80) | 13 (100) | 10 (100) | |
| Median | 4.00 | 4.00 | 10.00 | 10.00 | ||||||||
p<0.05 statistically significant
Legend: P0: before surgery; P1: 3 months after surgery; P2: 6 months after surgery TG: treated group; UTG: untreated group; CG: control group
Frequency of individuals according to muscle tone and mobility in each period of evaluation for the TG, UTG and CG
| Tone | Mobility | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Upper lip | Lower lip | Tongue | Lips | Tongue | |||||||
| TG | UTG | TG | UTG | TG | UTG | TG | UTG | TG | UTG | ||
| n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | ||
| P0 | adequate | 7 (53.84) | 4 (40.00) | 0 (0.00) | 1(10.00) | 1 (7.69) | 1 (10.00) | 7 (53.84) | 3 (30.00) | 4 (30.77) | 3 (30.00) |
| alteration | 6 (46.15) | 6 (60.00) | 13 (100) | 9 (90.00) | 12 (92.31) | 9 (90.00) | 6 (46.15) | 7 (70.00) | 9 (69.23) | 7 (70.00) | |
| P1 | adequate | 9 (69.23) | 6 (60.00) |
| 4 (40.00) | 6 (46.15) | 4 (40.00) | 10 (76.92) | 3 (30.00) |
| 1 (10.00) |
| alteration | 4 (30.77) | 4 (40.00) | 7 (53.84) | 6 (60.00) | 7 (53.84) | 6 (60.00) | 3 (23.07) | 7 (70.00) | 2 (15.38) | 9 (90.00) | |
| P2 | adequate | 0 (53.80) | 8 (80.00) | 8 (61.54) | 4 (40.00) | 6 (46.15) | 5 (50.00) | 11 (84.61) | 4 (40.00) | 11 (84.61) | 1 (10.00) |
| alteration | 3 (46.15) | 2 (20.00) | 5 (38.46) | 6 (60.00) | 7 (53.84) | 5 (50.00) | 2 (15.38) | 6 (60.00) | 2 (15.38) | 9 (90.00) | |
| CG | adequate | 12 (92.30) | 9 (90.00) | 11 (84.61) | 9 (90.00) | 13 (100.00) | 9 (90.00) | 11 (84.61) | 7 (70.00) | 8 (61.54) | 7 (70.00) |
| alteration | 1 (7.69) | 1 (10.00) | 2 (15.38) | 1 (10.00) | 0 (0.00) | 1 (10.00) | 2 (15.38) | 3 (30.00) | 5 (38.46) | 3 (30.00) | |
p<0.05,
p<0.01 statistically significant
Legend: P0: before surgery; P1: 3 months after surgery; P2: 6 months after surgery TG: treated group; UTG: untreated group; CG: control group
Statistical tests used: Comparison between periods and comparison with control: Fisher exact test
Means and standard deviation of the percentage of muscle activity for the TG, UTG and CG in the evaluation periods
| RM | LM | RT | LT | |||||
|---|---|---|---|---|---|---|---|---|
| TG | UTG | TG | UTG | TG | UTG | TG | UTG | |
| P0 | 71.57 | 93.96 | 88.17 | 69.8 | 77.52 | 65.76 | 67.57 | 57.08 |
| ±33.18 | ±57.66 | ±51.41 | ±41.04 | ±33.09 | ±15.86 | ±28.95 | ±23.66 | |
| P1 | 64.94 | 77.93 | 77.2 | 84.98 | 58.84 | 83.51 | 75.75 | 72.83 |
| ±21.39 | ±30.99 | ±36.62 | ±24.37 | ±16.51 | ±46.12 | ±54.08 | ±24.13 | |
| P2 | 75.14 | 92.54 | 79.6 | 88.7 | 64.1 | 64.57 | 66.91 | 67.2 |
| ±36.37 | ±33.14 | ±35.73 | ±29.24 | ±17.46 | ±23.72 | ±23.07 | ±25.66 | |
| CGα | 103.8 | 75.89 | 102.06 | 71.4 | 83.8 | 58 | 86.72 | 70.56 |
| ±40.01 | ±22.96 | ±42.33 | ±22.87 | ±20.89 | ±23.32 | ±24.52 | ±36.20 |
p<0.05 statistically significant
P0: before surgery; P1: 3 months after surgery; P2: 6 months after surgery; TG: treated group; UTG: untreated group; CG: control group
RM: right masseter; LM: left masseter; RT: right temporalis; LT: left temporalis
αCG was not treated
Statistical tests used: Comparison between periods Anova/Tukey or Friedman/Dunn; Comparison with control: Anova/Dunnet
Means and standard deviation of the act and cycle duration for the TG, UTG and CG in the evaluation periods between TG and UTG
| Act duration | cycle duration | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| RM | LM | RT | LT | RM | LM | RT | LT | |||||||||
| TG | UTG | TG | UTG | TG | UTG | TG | UTG | TG | UTG | TG | UTG | TG | UTG | TG | UTG | |
| P0 | 0.37 | 0.41 | 0.34 | 0.39 | 0.29 | 0.31 | 0.29 | 0.35 | 0.84 | 0.89 | 0.84 | 0.89 | 0.9 | 1.01 | 0.86 | 0.84 |
| ±0.11 | ±0.12 | ±0.14 | ±0.09 | ±0.08 | ±0.09 | ±0.09 | ±0.30 | ±0.18 | ±0.17 | ±0.25 | ±0.30 | ±0.23 | ±0.35 | ±0.21 | ±0.21 | |
| P1 | 0.35 | 0.32 | 0.33 | 0.32 | 0.29 | 0.29 | 0.3 | 0.3 | 0.81 | 0.74 | 0.8 | 0.71 | 0.84 | 0.79 | 0.83 | 0.74 |
|
|
|
| ±0.05 | ±0.12 | ±0.09 | ±0.10 | ±0.09 |
| ±0.08 | ±0.26 | ±0.19 | ±0.26 | ±0.14 | ±0.26 | ±0.06 | |
| P2 | 0.29 | 0.32 | 0.28 | 0.3 | 0.23 | 0.27 | 0.25 | 0.26 | 0.68 | 0.77 | 0.7 | 0.74 | 0.72 | 0.78 | 0.74 | 0.78 |
| ±0.05 | ±0.08 | ±0.05 | ±0.06 | ±0.06 | ±0.06 | ±0.05 | ±0.04 | ±0.15 | ±0.12 | ±0.14 | ±0.06 | ±0.16 | ±0.09 | ±0.20 | ±0.06 | |
| CGα | 0.26 | 0.26 | 0.26 | 0.27 | 0.25 | 0.24 | 0.24 | 0.23 | 0.74 | 0.74 | 0.72 | 0.74 | 0.74 | 0.76 | 0.74 | 0.75 |
| ±0.05 | ±0.04 | ±0.04 | ±0.06 | ±0.04 | ±0.04 | ±0.04 | ±0.04 | ±0.09 | ±0.09 | ±0.09 | ±0.09 | ±0.08 | ±0.12 | ±0.07 | ±0.13 | |
p<0.05 statistically significant
P0: before surgery; P1: 3 months after surgery; P2: 6 months after surgery; TG: treated group; UTG: untreated group; CG: control group
RM: right masseter; LM: left masseter; RT: right temporalis; LT: left temporalis
αCG was not treated
Statistical tests used: Comparison between periods: Anova/Tukey or Friedman/Dunn; Comparison with control: Anova/Dunnet
Means and standard deviation of the number of cycles for the TG, UTG and CG in the evaluation periods
| Number of cycles | ||
|---|---|---|
| TG | UTG | |
| P0 | 11.34 | 10.53 |
| ±2.87 | ±1.82 | |
| P1 |
| 12.63 |
| ±2.45 | ±1.16 | |
| P2 | 13.79 | 12.6 |
| ±2.44 | ±1.24 | |
| CGα | 12.55 | 12.6 |
| ±1.42 | ±1.87 | |
p<0.05 statistically significant
P0: before surgery; P1: 3 months after surgery; P2: 6 months after surgery; TG: treated group; UTG: untreated group; CG: control group
RM: right masseter; LM: left masseter; RT: right temporalis; LT: left temporalis
αCG was not treated
Statistical tests used: Comparison between periods: Anova/Tukey; Comparison with control: Anova/Dunnet
Figure 4Individuals classified according to the chewing side preference